雪榕生物：预计2025年归母净利润为2900万元至4000万元

Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of between 29 million and 40 million yuan in 2025, marking a turnaround from losses in previous years [1] Group 1: Industry Outlook - The edible mushroom industry is anticipated to stabilize and recover in the second half of 2025 after a prolonged adjustment period, leading to an increase in the prices of main products and an improvement in gross margins [1] Group 2: Company Performance Drivers - Breakthroughs in new strains of white enoki mushrooms are expected to significantly enhance production capacity utilization and reduce overall costs in the second half of 2025 [1] - The company is actively implementing quality improvement and efficiency enhancement measures, resulting in a reduction of approximately 45 million yuan in period expenses year-on-year [1] Group 3: Non-Recurring Gains - The company estimates that non-recurring gains will contribute approximately 24 million yuan to net profit in 2025, primarily from government subsidies and asset disposal gains [1]